SUBSCRIBE
SUBSCRIBE

Tennessee

Business partners shaking hands after closing a deal
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
December 19, 2024
 · 
3 min read
Press Releases
Aegis Sciences Corporation Collaborates with The McNabb Center to Evaluate the Impact of Xylazine Exposure on Opioid Withdrawal
December 17, 2024
 · 
3 min read
Press Releases
Healthcare Integrated Technologies, Inc. Welcomes Tim Brady as its Full-Time Chief Financial Officer
December 16, 2024
 · 
3 min read
Press Releases
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
December 12, 2024
 · 
5 min read
Press Releases
Aegis Sciences Corporation Announces Updates for NPS Testing
December 10, 2024
 · 
2 min read
Press Releases
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
December 9, 2024
 · 
9 min read
Press Releases
Sarah Cannon Research Institute to Showcase Latest Research Insights at the 2024 ASH Annual Meeting & Exposition
December 6, 2024
 · 
4 min read
Press Releases
OneOncology Partner Practice Investigators to Present 26 Abstracts at ASH Annual Meeting
December 4, 2024
 · 
1 min read
Press Releases
Enigma Biomedical USA Announces Formation of Scientific Advisory Board
December 3, 2024
 · 
3 min read
Press Releases
Radiology Partners and RADPAIR Forge Strategic Partnership Focused on Generative AI Solutions for Radiology
December 2, 2024
 · 
4 min read
Press Releases
Slope and LabConnect Unveil Groundbreaking Bidirectional API Integration for Clinical Trials
November 25, 2024
 · 
3 min read
Press Releases
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
November 20, 2024
 · 
4 min read
Press Releases
EndoTheia Announces Successful Clinical Trial of FlexStone, the World’s First Independently Steerable Kidney Stone Basket Surgical Device
November 19, 2024
 · 
4 min read
Press Releases
Harrow Announces Participation in Upcoming Investor Conferences
November 15, 2024
 · 
1 min read
Press Releases
Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis
November 13, 2024
 · 
4 min read
Press Releases
Sarah Cannon Research Institute Appoints Director of Lymphoma Research
November 13, 2024
 · 
2 min read
Press Releases
Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update
November 8, 2024
 · 
15 min read
Press Releases
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products
November 7, 2024
 · 
4 min read
Press Releases
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
October 31, 2024
 · 
1 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
October 25, 2024
 · 
3 min read
Load More